Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 0.52 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30202898 | 0.92 | DRD2 (0.57) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL16231598 | 0.85 | DRD2 (0.60) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL31420883 | 0.85 | CACNA1H (0.51) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL24951903 | 0.84 | DRD2 (0.55) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL15686281 | 0.82 | DRD2 (0.53) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL16232049 | 0.81 | DRD2 (0.55) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL4024516 | 0.81 | DRD2 (0.56) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL31301250 | 0.81 | DRD2 (0.56) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL24172673 | 0.81 | DRD2 (0.56) | DRD2CACNA1HTDP1EPHX1MEN1 | |
| SCHEMBL31301242 | 0.80 | DRD2 (0.63) | DRD2CACNA1HTDP1EPHX1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2025064718-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | DRD2 2243/4885CACNA1H 4160/4885TDP1 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.